Health
J&J starts human study of COVID-19 vaccine after promising monkey data – Yahoo Finance
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in nasal swabs, according to the study published…
By Julie Steenhuysen
(Reuters) – Johnson & Johnson <JNJ.N> on Thursday kicked off U.S. human safety trials for its COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
When exposed to the virus, six out of six animals who got the vaccine candidate were completely protected from lung disease and five out of six were protected from infection as measured by the presence of virus in na…
-
Noosa News10 hours agoMan arrested following alleged armed rape and kidnapping in Maroochydore
-
Business10 hours agoUp 113% in a year, ASX 200 gold stock reports Q1 sales of 91,477 ounces
-
General7 hours agoCarnarvon locals help rescue tourist hit by ‘king wave’ along Quobba coastline
-
Business9 hours agoWhy Amplitude Energy, Brazilian Rare Earths, Nexgen, and Northern Star shares are falling today